N -Cinnamoylated Aminoquinolines as Promising Antileishmanial Agents
Author(s) -
Sílvia Vale-Costa,
Joana Costa-Gouveia,
Bianca Pérez,
Tânia Silva,
Cátia Teixeira,
Paula Gomes,
Maria Salomé Gomes
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00557-13
Subject(s) - primaquine , chloroquine , pharmacology , in vitro , aminoquinolines , chemistry , amastigote , toxicity , leishmania , biology , malaria , biochemistry , combinatorial chemistry , immunology , parasite hosting , organic chemistry , world wide web , computer science
A series of cinnamic acid conjugates of primaquine and chloroquine were evaluated for their in vitro antileishmanial activities. Although primaquine derivatives had modest activity, chloroquine conjugates exhibited potent activity against both promastigotes (50% inhibitory concentration [IC50] = 2.6 to 21.8 μM) and intramacrophagic amastigotes (IC50 = 1.2 to 9.3 μM) of Leishmania infantum. Both the high activity of these chloroquine analogues and their mild-to-low toxicity toward host cells make them promising leads for the discovery of new antileishmanial agents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom